- Statement of Changes in Beneficial Ownership (4)
August 10 2012 - 3:51PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Rudelius Robert James
|
2. Issuer Name
and
Ticker or Trading Symbol
ProUroCare Medical Inc.
[
PUMD
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Last)
(First)
(Middle)
800 4TH STREET SW, #N821
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
8/9/2012
|
(Street)
WASHINGTON, DC 20024
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common stock, $0.00001 par value
|
|
|
|
|
|
|
|
34756
|
I
|
By Noble Ventures, of which reporting person is the majority owner.
|
Common stock, $0.00001 par value
|
|
|
|
|
|
|
|
110205
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Stock Options
|
$2.90
|
|
|
|
|
|
|
(1)
|
6/12/2014
|
Common Stock, $0.00001 par value
|
3000
|
|
3000
|
D
|
|
Stock options
|
$1.00
|
|
|
|
|
|
|
(1)
|
8/12/2015
|
Common stock, $0.00001 par value
|
1000
|
|
1000
|
D
|
|
Warrants
|
$0.50
|
|
|
|
|
|
|
(1)
|
12/31/2012
|
Common Stock, $0.00001 par value
|
4000
|
|
4000
|
D
|
|
Warrants
|
$0.50
|
|
|
|
|
|
|
(1)
|
12/31/2012
|
Common stock, $0.00001 par value
|
2000
|
|
2000
|
I
|
By Noble Ventures, of which reporting person is the majority owner
|
Stock Options
|
$0.85
|
|
|
|
|
|
|
(1)
|
3/3/2016
|
Common stock, $0.00001 par value
|
20000
|
|
20000
|
D
|
|
Stock options
|
$1.25
|
|
|
|
|
|
|
(1)
|
8/11/2016
|
Common stock, $0.00001 par value
|
1000
|
|
1000
|
D
|
|
Stock Options
|
$1.50
|
|
|
|
|
|
|
(1)
|
9/29/2016
|
Common stock, $0.00001 par value
|
30000
|
|
30000
|
D
|
|
Warrants
|
$1.30
|
|
|
|
|
|
|
(1)
|
1/7/2014
|
Common stock, $0.00001 par value
|
19986
|
|
19986
|
D
|
|
Warrants
|
$1.30
|
|
|
|
|
|
|
(1)
|
11/12/2012
|
Common stock, $0.00001 par value
|
10000
|
|
10000
|
D
|
|
Warrants
|
$1.30
|
|
|
|
|
|
|
(1)
|
7/12/2013
|
Common stock, $0.00001 par value
|
10000
|
|
10000
|
I
|
Held by Noble Ventures, of which reporting person is the majority owner.
|
Warrants
|
$1.30
|
|
|
|
|
|
|
(1)
|
11/12/2012
|
Common stock, $0.00001 par value
|
4756
|
|
4756
|
I
|
By Noble Ventures, of which reporting person is majority owner.
|
Warrants
|
$1.30
|
|
|
|
|
|
|
(1)
|
8/2/2013
|
Common stock, $0.00001 par value
|
10000
|
|
10000
|
I
|
By Noble ventures, of which reporting person is majority owner
|
Warrants
|
$1.30
|
|
|
|
|
|
|
(1)
|
8/2/2010
|
Commons stock, $0.00001 par value
|
10000
|
|
10000
|
D
|
|
Options
|
$1.72
|
|
|
|
|
|
|
(1)
|
8/10/2017
|
Common stock, $0.00001 par value
|
14535
|
|
14535
|
D
|
|
Stock options
|
$0.87
|
|
|
|
|
|
|
(1)
|
8/9/2018
|
Common stock, $0.00001 par value
|
28736
|
|
28736
|
D
|
|
Convertible Note
|
$1.10
|
|
|
|
|
|
|
(1)
|
8/28/2012
|
Common stock, $0.00001 par value
|
(3)
|
|
$6400
|
D
|
|
Stock Options
|
$0.60
|
8/9/2012
|
|
A
|
|
25000
|
|
(2)
|
8/9/2019
|
Common stock, $0.00001 par value
|
25000
|
$0
|
25000
|
D
|
|
Explanation of Responses:
|
(
1)
|
Currently exercisable
|
(
2)
|
Annual option award pursuant to the Issuer's compensation policy for Directors upon their re-election to the Board of Directors. The seven-year options vest ratably over 12 months.
|
(
3)
|
On December 1, 2011, the reporting person and the Company executed a convertible promissory note in the principal amount of $6,400 with a maturity date of February 28, 2012. The maturity date was subsequently changed to August 28, 2012. The principal amount and interest accruing at a rate of 10% per year are convertible into common shares at $1.10 per share at any time through the maturity date. The number of shares to be issued upon conversion will be fixed on the conversion date and reported on a Form 4 within 2 business days after conversion. The issuer's Board of Directors specifically approved the transaction as exempt from the requirements of Section 16b as provided by Rules 16b-3(d).
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Rudelius Robert James
800 4TH STREET SW
#N821
WASHINGTON, DC 20024
|
X
|
|
|
|
Signatures
|
Richard B. Thon by power of attorney
|
|
8/10/2012
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Sep 2024 to Oct 2024
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Oct 2023 to Oct 2024